Loading content

Dr Jaime Peters

Senior Research Fellow

6068

South Cloisters 

Jaime's background is in medical statistics and evidence synthesis. Her interests have spread to decision modelling and health economics, having developed and critiqued a number of economic analyses to inform decision-making nationally (for the National Institute of Health and Clinical Excellence) and locally for the South West Peninsula Health Technology Commissioning Group. More recently her work has focused on the area of test evaluation and she is a member of the Exeter Test Group http://medicine.exeter.ac.uk/testgroup/.

Broad research specialisms:

  • Health economic modelling, particularly for the evaluation of tests
  • Systematic review and meta-analysis methods for the evaluation of tests
  • Methods for expert elicitation and its incorporation in health economic models
  • Issues of bias in the publication and reporting of studies in health
  • General methods for evidence synthesis

Qualifications

  • PhD (University of Leicester, 2007)
  • MSc (University of Leicester, 2000)
  • BSc (University of Keele, 1998)

Research

Research interests

Jaime's main research interests are in the areas of health economic modelling and evidence synthesis. With respect to modelling, she has a particular interest in the use and inclusion of evidence in such models, e.g. the use of elicitation methods to obtain expert opinion to help inform modelling, and also in the identification of evidence to parameterise decision models.

Jaime is mainly involved in the application of evidence synthesis and decision modelling to the evaluation of tests. She has recently been involved in two studies related to the diagnosis of diabetes. One of these (funded by the Wellcome Trust and the Department of Health) concerns the cost-effectiveness of strategies to screen individuals with diabetes to identify those with a genetic form, who may benefit from a change to less invasive and less costly treatment. The second study (funded by the NIHR’s Research for Patient Benefit programme) is a systematic review of the evidence to identify clinical criteria to predict absolute insulin deficiency, a measure of type 1 diabetes.

Jaime has also continued her interest in issues of publication and reporting bias in a study looking at the use and impact of a particular reporting guideline for non-randomised studies (TREND).

Research projects

  • Using pharmacogenetics to improve treatment in young-onset diabetes
  • Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency
  • Assessing the current state of decision models evaluating:
    • diagnostic and prognostic prediction models (with colleagues in the Netherlands) and,
    • pharmacogenetic and pharmacogenomic tests.
  • Exploring the value of CTCA to predict cardiovascular risk (PhD student Chun Pang)
  • An evaluation of methods for eliciting expert opinion in health technology assessment (completed PhD project by Bogdan Grigore)
  • Evaluating the impact and use of Transparent Reporting of Evaluations with Non-randomised Designs (TREND) reporting guidelines
  • Developing a network and increasing knowledge for researchers involved in decision modelling

Grants/Funding

  • Tender to undertake Technology Assessment Reviews (TARs). National Institute for Health Research. April 2016 – March 2021.
  • Brazil-UK collaboration in Health Technology Assessment of diagnostic strategies for infectious diseases. Research Councils UK-Conselho Nacional das Fundacoes Estaduais de Amparo a Pesquisa Jan 2015 - Dec 2015.
  • Developing a network and increasing knowledge for researchers involved in decision modelling. University of Exeter Researcher-Led Initiative. Feb 2013 - July 2013.
  • Deriving evidence-based clinical criteria to aid classification of diabetes. Research for Patient Benefit. Sept 2012 - August 2014.
  • Are interventions to reduce the impact of arsenic contamination of groundwater on human health and crop productivity in developing countries effective? 3ie, DFID and AusAID joint call. May 2011 - May 2012.
  • Using pharmacogenetics to improve treatment in young-onset diabetes. Health Innovation Challenge Fund: Dept Health and Wellcome Trust. Oct 2010 - Oct 2013.
  • Methods for generalised synthesis of evidence in setting standards for safe human exposure to environmental chemicals. Dept Health National Coordinating Centre Research Capacity and Development Research Scientist in Evidence Synthesis (Personal Fellowship). Oct 2003 - Oct 2006.

Key publications | Publications by category | Publications by year

Key publications


Shields BM, Peters JL, Cooper C, Lowe J, Knight BA, Powell RJ, Jones A, Hyde CJ, Hattersley AT (2015). Can clinical features be used to differentiate type 1 from type 2 diabetes? a systematic review of the literature. BMJ Open, 5(11). Abstract.  Author URL.  Full text.
Peters JL, Cooper C, Buchanan J (2015). Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol. BMJ Open, 5(11). Abstract.  Author URL.  Full text.
Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS (2015). Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. J Clin Epidemiol, 68(7), 833-842. Abstract.  Author URL.  Full text.
Fuller T, Peters J, Pearson M, Anderson R (2014). Impact of the transparent reporting of evaluations with nonrandomized designs reporting guideline: ten years on. Am J Public Health, 104(11), e110-e117. Abstract.  Author URL.
Hoyle M, Peters J, Crathorne L, Jones-Hughes T, Cooper C, Napier M, Hyde C (2013). Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer. Value Health, 16(2), 288-296. Abstract.  Author URL.
Peters JL, Anderson R, Hyde C (2013). Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes. BMJ Open, 3(5). Abstract.  Full text.

Publications by category


Journal articles

Peters J, Fuller T, Pearson M (In Press). Improving the reporting of health and psychological research. Australian Psychologist Full text.
Shields BM, Peters JL, Cooper C, Lowe J, Knight BA, Powell RJ, Jones A, Hyde CJ, Hattersley AT (2015). Can clinical features be used to differentiate type 1 from type 2 diabetes? a systematic review of the literature. BMJ Open, 5(11). Abstract.  Author URL.  Full text.
Peters JL, Cooper C, Buchanan J (2015). Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol. BMJ Open, 5(11). Abstract.  Author URL.  Full text.
Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS (2015). Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. J Clin Epidemiol, 68(7), 833-842. Abstract.  Author URL.  Full text.
Fuller T, Pearson M, Peters J, Anderson R (2015). What affects authors' and editors' use of reporting guidelines? Findings from an online survey and qualitative interviews. PLoS One, 10(4). Abstract.  Author URL.  Full text.
Fuller T, Peters J, Pearson M, Anderson R (2014). Impact of the transparent reporting of evaluations with nonrandomized designs reporting guideline: ten years on. Am J Public Health, 104(11), e110-e117. Abstract.  Author URL.
Hoyle M, Peters J, Crathorne L, Jones-Hughes T, Cooper C, Napier M, Hyde C (2013). Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer. Value Health, 16(2), 288-296. Abstract.  Author URL.
Peters JL, Anderson R, Hyde C (2013). Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes. BMJ Open, 3(5). Abstract.  Full text.
Peters JL, Anderson R, Hoyle M, Hyde C (2013). Evolution of a cost-utility model of donepezil for Alzheimer's disease. Int J Technol Assess Health Care, 29(2), 147-154. Abstract.  Author URL.
Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P, Moxham T, et al (2013). Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model. Age Ageing, 42(1), 14-20. Abstract.  Author URL.
Grigore B, Peters J, Hyde C, Stein K (2013). Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics, 31(11), 991-1003. Abstract.  Author URL.  Full text.
Hoyle M, Crathorne L, Peters J, Jones-Hughes T, Cooper C, Napier M, Tappenden P, Hyde C (2013). The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model. Health Technol Assess, 17(14), 1-237. Abstract.  Author URL.  Full text.
Peters JL, Anderson R (2013). The cost-effectiveness of mandatory 20 mph zones for the prevention of injuries. J Public Health (Oxf), 35(1), 40-48. Abstract.  Author URL.
Peters JL, Moreno SG, Phillips B, Sutton AJ (2012). Are we sure about the evidence for zinc in prophylaxis of the common cold?. Expert Review of Respiratory Medicine, 6(1), 15-16.
Lu L, Peters J, Roome C, Stein K (2012). Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU International, 109(8), 1183-1192. Abstract.
Lu L, Peters J, Roome C, Stein K (2012). Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care, 28(3), 241-248. Abstract.  Author URL.
Fuller T, Pearson M, Peters JL, Anderson R (2012). Evaluating the impact and use of Transparent Reporting of Evaluations with Non-randomised Designs (TREND) reporting guidelines. BMJ Open, 2(6). Abstract.  Author URL.  Full text.
Shields BM, Peters JL, Cooper C, Powell RJ, Knight BA, Hyde C, Hattersley AT (2012). Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol. BMJ Open, 2(6). Abstract.  Author URL.  Full text.
Pearson M, Peters J (2012). Outcome reporting bias in evaluations of public health interventions: evidence of impact and the potential role of a study register. J Epidemiol Community Health, 66(4), 286-289. Abstract.  Author URL.
Pearson M, Hunt H, Garside R, Moxham T, Peters J, Anderson R (2012). Preventing unintentional injuries to children under 15 years in the outdoors: a systematic review of the effectiveness of educational programs. Injury Prevention, 18(2), 113-123. Abstract.  Full text.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, et al (2012). The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess, 16(21), 1-470. Abstract.  Author URL.  Full text.
Pearson M, Jones-Hughes T, Whear R, Cooper C, Peters J, Evans EH, Depledge M (2011). Are interventions to reduce the impact of arsenic contamination of groundwater on human health in developing countries effective?: a systematic review protocol. Environmental Evidence Author URL.
Pearson M, Jones-Hughes T, Whear R, Cooper C, Peters J, Evans EH, Depledge M (2011). Are interventions to reduce the impact of arsenic contamination of groundwater on human health in developing countries effective?: a systematic review protocol. Environmental Evidence, 1, 1-7. Author URL.
Cooper NJ, Peters J, Lai MCW, Juni P, Wandel S, Palmer S, Paulden M, Conti S, Welton NJ, Abrams KR, et al (2011). How valuable are multiple treatment comparison methods in evidence-based health-care evaluation. Value in Health, 14(2), 371-380. Abstract.
Peason MN, Hunt HA, Garside R, Moxham T, Peters J, Anderson R (2011). Preventing unintentional injuries to children under 15 years in the outdoors: a systematic review of the effectiveness of educational programs. Inj Prev, 2(18). Abstract.  Author URL.
Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, et al (2011). Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (Online), 343(7818).
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, Moreno SG (2010). Assessing publication bias in meta-analyses in the presence of between-study heterogeneity. Journal of the Royal Statistical Society. Series A: Statistics in Society, 173(3), 575-591. Abstract.
Stahl-Timmins W, Pitt M, Peters J (2010). Graphical presentation of data for health policy decisions: an exploratory online decision task experiment to measure efectiveness. Information Design Journal, 18(3), 205-224. Abstract.
Moreno SG, Sutton AJ, Ades AE, Stanley TD, Abrams KR, Peters JL, Cooper NJ (2009). Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol, 9 Abstract.  Author URL.
Higgins M, Theobald KA, Peters J (2009). Can nurses do more for patients to reduce vascular access and cardiac complications following PCI?. AUSTRALIAN CRITICAL CARE, 22(1), 57-58. Author URL.
Jones DR, Peters JL, Rushton L, Sutton AJ, Abrams KR (2009). Interspecies extrapolation in environmental exposure standard setting: a Bayesian synthesis approach. Regul Toxicol Pharmacol, 53(3), 217-225. Abstract.  Author URL.
Palmer TM, Peters JL, Sutton AJ, Moreno SG (2008). Contour-enhanced funnel plots for meta-analysis. Stata Journal, 8(2), 242-254. Abstract.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008). Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol, 61(10), 991-996. Abstract.  Author URL.
Peters JL, Mengersen KL (2008). Meta-analysis of repeated measures study designs. J Eval Clin Pract, 14(5), 941-950. Abstract.  Author URL.
Peters J, Mengersen K (2008). Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses. Eval Health Prof, 31(4), 370-389. Abstract.  Author URL.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008). The Contribution of Systematic Review and Meta-Analysis Methods to Human Health Risk Assessment: Neurobehavioral Effects of Manganese. HUMAN AND ECOLOGICAL RISK ASSESSMENT, 14(6), 1250-1272. Author URL.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2007). Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med, 26(25), 4544-4562. Abstract.  Author URL.
Peters JL, Sutton AJ, Jones DR, Rushton L, Abrams KR (2006). A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. Journal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural Wastes, 41(7), 1245-1258. Abstract.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295(6), 676-680. Abstract.  Author URL.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006). The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med, 23(11), 1165-1173. Abstract.  Author URL.
Peters JL, Rushton L, Button AJ, Jones DR, Abrams KR, Mugglestone MA (2005). Bayesian methods for the cross-design synthesis of epidemiological and toxicological evidence. Journal of the Royal Statistical Society. Series C: Applied Statistics, 54(1), 159-172. Abstract.

Conferences

Zhelev Z, Patel K, Youngman E, Peters J, Lowe J, Cooper C, Shields B, Hattersley A, Hyde C (2016). Autoantibody status as a predictor of future insulin deficiency in patients with diabetes: a systematic review.  Author URL.
Peters JL, Anderson R, Shields BM, King S, Hudson M, Shepherd M, McDonald TJ, Pearson E, Hattersley AT, Hyde C, et al (2016). Strategies to identify individuals with MODY: results of a health economic model.  Author URL.
Van Giessen A, Wilcher B, Peters J, Hyde C, Moons KG, de Wit GA, Koffijberg H (2014). HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW.  Author URL.
Shields BM, Peters JL, Cooper C, Lowe J, Knight B, Powell R, Hyde CJ, Hattersley AT (2014). Is there an evidence base for the clinical features used to differentiate type 1 from type 2 diabetes? a systematic review of the literature.  Author URL.
Grigore B, Peters J, Hyde C, Stein K (2013). REPRESENTING UNCERTAINTY OF EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT THROUGH THE USE OF SUBJECTIVE PROBABILITIES.  Author URL.
Peters JL, Hoyle M, Anderson R (2010). STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMER'S DISEASE.  Author URL.
Peters JL, Jones DR, Rushton L, Sutton AJ, Abrams KR, Mugglestone MA (2003). Bayesian methods for the synthesis of epidemiological and toxicological evidence.  Author URL.
Peters JL, Rushton L, Jones DR, Sutton AJ, Abrams KR, Mugglestone MA (2002). Setting environmental exposure standards: Sensitivity analyses for the synthesis of epidemiological and toxicological evidence.  Author URL.

Reports

Huxley N, Crathorne L, Varley-Campbell J, Tikhonova I, Snowsill T, Briscoe S, Peters J, Bond M, Napier M, Hoyle MW, et al (2015). Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer. MTA for NICE. Author URL.
Jones-Hughes T, Snowsill T, Haasova M, Coelho H, Crathorne L, Cooper C, Mujica-Mota R, Peters J, Varley-Campbell J, Huxley N, et al (2015). Immunosuppressive therapy for kidney transplantation in adults (review of technology appraisal guidance 85). MTA for NICE. Author URL.

Publications by year


In Press

Peters J, Fuller T, Pearson M (In Press). Improving the reporting of health and psychological research. Australian Psychologist Full text.

2016

Zhelev Z, Patel K, Youngman E, Peters J, Lowe J, Cooper C, Shields B, Hattersley A, Hyde C (2016). Autoantibody status as a predictor of future insulin deficiency in patients with diabetes: a systematic review.  Author URL.
Peters JL, Anderson R, Shields BM, King S, Hudson M, Shepherd M, McDonald TJ, Pearson E, Hattersley AT, Hyde C, et al (2016). Strategies to identify individuals with MODY: results of a health economic model.  Author URL.

2015

Shields BM, Peters JL, Cooper C, Lowe J, Knight BA, Powell RJ, Jones A, Hyde CJ, Hattersley AT (2015). Can clinical features be used to differentiate type 1 from type 2 diabetes? a systematic review of the literature. BMJ Open, 5(11). Abstract.  Author URL.  Full text.
Huxley N, Crathorne L, Varley-Campbell J, Tikhonova I, Snowsill T, Briscoe S, Peters J, Bond M, Napier M, Hoyle MW, et al (2015). Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer. MTA for NICE. Author URL.
Peters JL, Cooper C, Buchanan J (2015). Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol. BMJ Open, 5(11). Abstract.  Author URL.  Full text.
Jones-Hughes T, Snowsill T, Haasova M, Coelho H, Crathorne L, Cooper C, Mujica-Mota R, Peters J, Varley-Campbell J, Huxley N, et al (2015). Immunosuppressive therapy for kidney transplantation in adults (review of technology appraisal guidance 85). MTA for NICE. Author URL.
Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS (2015). Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. J Clin Epidemiol, 68(7), 833-842. Abstract.  Author URL.  Full text.
Fuller T, Pearson M, Peters J, Anderson R (2015). What affects authors' and editors' use of reporting guidelines? Findings from an online survey and qualitative interviews. PLoS One, 10(4). Abstract.  Author URL.  Full text.

2014

Van Giessen A, Wilcher B, Peters J, Hyde C, Moons KG, de Wit GA, Koffijberg H (2014). HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW.  Author URL.
Fuller T, Peters J, Pearson M, Anderson R (2014). Impact of the transparent reporting of evaluations with nonrandomized designs reporting guideline: ten years on. Am J Public Health, 104(11), e110-e117. Abstract.  Author URL.
Shields BM, Peters JL, Cooper C, Lowe J, Knight B, Powell R, Hyde CJ, Hattersley AT (2014). Is there an evidence base for the clinical features used to differentiate type 1 from type 2 diabetes? a systematic review of the literature.  Author URL.

2013

Hoyle M, Peters J, Crathorne L, Jones-Hughes T, Cooper C, Napier M, Hyde C (2013). Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer. Value Health, 16(2), 288-296. Abstract.  Author URL.
Peters JL, Anderson R, Hyde C (2013). Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes. BMJ Open, 3(5). Abstract.  Full text.
Peters JL, Anderson R, Hoyle M, Hyde C (2013). Evolution of a cost-utility model of donepezil for Alzheimer's disease. Int J Technol Assess Health Care, 29(2), 147-154. Abstract.  Author URL.
Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P, Moxham T, et al (2013). Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model. Age Ageing, 42(1), 14-20. Abstract.  Author URL.
Grigore B, Peters J, Hyde C, Stein K (2013). Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics, 31(11), 991-1003. Abstract.  Author URL.  Full text.
Grigore B, Peters J, Hyde C, Stein K (2013). REPRESENTING UNCERTAINTY OF EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT THROUGH THE USE OF SUBJECTIVE PROBABILITIES.  Author URL.
Hoyle M, Crathorne L, Peters J, Jones-Hughes T, Cooper C, Napier M, Tappenden P, Hyde C (2013). The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model. Health Technol Assess, 17(14), 1-237. Abstract.  Author URL.  Full text.
Peters JL, Anderson R (2013). The cost-effectiveness of mandatory 20 mph zones for the prevention of injuries. J Public Health (Oxf), 35(1), 40-48. Abstract.  Author URL.

2012

Peters JL, Moreno SG, Phillips B, Sutton AJ (2012). Are we sure about the evidence for zinc in prophylaxis of the common cold?. Expert Review of Respiratory Medicine, 6(1), 15-16.
Lu L, Peters J, Roome C, Stein K (2012). Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU International, 109(8), 1183-1192. Abstract.
Lu L, Peters J, Roome C, Stein K (2012). Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care, 28(3), 241-248. Abstract.  Author URL.
Fuller T, Pearson M, Peters JL, Anderson R (2012). Evaluating the impact and use of Transparent Reporting of Evaluations with Non-randomised Designs (TREND) reporting guidelines. BMJ Open, 2(6). Abstract.  Author URL.  Full text.
Shields BM, Peters JL, Cooper C, Powell RJ, Knight BA, Hyde C, Hattersley AT (2012). Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol. BMJ Open, 2(6). Abstract.  Author URL.  Full text.
Pearson M, Peters J (2012). Outcome reporting bias in evaluations of public health interventions: evidence of impact and the potential role of a study register. J Epidemiol Community Health, 66(4), 286-289. Abstract.  Author URL.
Pearson M, Hunt H, Garside R, Moxham T, Peters J, Anderson R (2012). Preventing unintentional injuries to children under 15 years in the outdoors: a systematic review of the effectiveness of educational programs. Injury Prevention, 18(2), 113-123. Abstract.  Full text.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, et al (2012). The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess, 16(21), 1-470. Abstract.  Author URL.  Full text.

2011

Pearson M, Jones-Hughes T, Whear R, Cooper C, Peters J, Evans EH, Depledge M (2011). Are interventions to reduce the impact of arsenic contamination of groundwater on human health in developing countries effective?: a systematic review protocol. Environmental Evidence Author URL.
Pearson M, Jones-Hughes T, Whear R, Cooper C, Peters J, Evans EH, Depledge M (2011). Are interventions to reduce the impact of arsenic contamination of groundwater on human health in developing countries effective?: a systematic review protocol. Environmental Evidence, 1, 1-7. Author URL.
Cooper NJ, Peters J, Lai MCW, Juni P, Wandel S, Palmer S, Paulden M, Conti S, Welton NJ, Abrams KR, et al (2011). How valuable are multiple treatment comparison methods in evidence-based health-care evaluation. Value in Health, 14(2), 371-380. Abstract.
Peason MN, Hunt HA, Garside R, Moxham T, Peters J, Anderson R (2011). Preventing unintentional injuries to children under 15 years in the outdoors: a systematic review of the effectiveness of educational programs. Inj Prev, 2(18). Abstract.  Author URL.
Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, et al (2011). Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (Online), 343(7818).

2010

Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, Moreno SG (2010). Assessing publication bias in meta-analyses in the presence of between-study heterogeneity. Journal of the Royal Statistical Society. Series A: Statistics in Society, 173(3), 575-591. Abstract.
Stahl-Timmins W, Pitt M, Peters J (2010). Graphical presentation of data for health policy decisions: an exploratory online decision task experiment to measure efectiveness. Information Design Journal, 18(3), 205-224. Abstract.
Peters JL, Hoyle M, Anderson R (2010). STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMER'S DISEASE.  Author URL.

2009

Moreno SG, Sutton AJ, Ades AE, Stanley TD, Abrams KR, Peters JL, Cooper NJ (2009). Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol, 9 Abstract.  Author URL.
Higgins M, Theobald KA, Peters J (2009). Can nurses do more for patients to reduce vascular access and cardiac complications following PCI?. AUSTRALIAN CRITICAL CARE, 22(1), 57-58. Author URL.
Jones DR, Peters JL, Rushton L, Sutton AJ, Abrams KR (2009). Interspecies extrapolation in environmental exposure standard setting: a Bayesian synthesis approach. Regul Toxicol Pharmacol, 53(3), 217-225. Abstract.  Author URL.

2008

Palmer TM, Peters JL, Sutton AJ, Moreno SG (2008). Contour-enhanced funnel plots for meta-analysis. Stata Journal, 8(2), 242-254. Abstract.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008). Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol, 61(10), 991-996. Abstract.  Author URL.
Peters JL, Mengersen KL (2008). Meta-analysis of repeated measures study designs. J Eval Clin Pract, 14(5), 941-950. Abstract.  Author URL.
Peters J, Mengersen K (2008). Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses. Eval Health Prof, 31(4), 370-389. Abstract.  Author URL.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008). The Contribution of Systematic Review and Meta-Analysis Methods to Human Health Risk Assessment: Neurobehavioral Effects of Manganese. HUMAN AND ECOLOGICAL RISK ASSESSMENT, 14(6), 1250-1272. Author URL.

2007

Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2007). Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med, 26(25), 4544-4562. Abstract.  Author URL.

2006

Peters JL, Sutton AJ, Jones DR, Rushton L, Abrams KR (2006). A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. Journal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural Wastes, 41(7), 1245-1258. Abstract.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295(6), 676-680. Abstract.  Author URL.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006). The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med, 23(11), 1165-1173. Abstract.  Author URL.

2005

Peters JL, Rushton L, Button AJ, Jones DR, Abrams KR, Mugglestone MA (2005). Bayesian methods for the cross-design synthesis of epidemiological and toxicological evidence. Journal of the Royal Statistical Society. Series C: Applied Statistics, 54(1), 159-172. Abstract.

2003

Peters JL, Jones DR, Rushton L, Sutton AJ, Abrams KR, Mugglestone MA (2003). Bayesian methods for the synthesis of epidemiological and toxicological evidence.  Author URL.

2002

Peters JL, Rushton L, Jones DR, Sutton AJ, Abrams KR, Mugglestone MA (2002). Setting environmental exposure standards: Sensitivity analyses for the synthesis of epidemiological and toxicological evidence.  Author URL.

Undergraduate: Jaime contributes to the Making Sense of Evidence modules for 1st and 2nd year BMBS students, and is an Academic Tutor for this programme.

Postgraduate: Jaime contributes to the MSc in Applied Health Services Research, and related Continuing Professional Development courses.

Back | Edit Profile